Motac is a preclinical research company dedicated to working with pharmaceutical and biotechnology companies that are developing new treatments for diseases of the central nervous system.
Motac in-house personnel include internationally-recognized experts in neuroanatomy, neurophysiology, neuropharmacology and neuropsychology.
As a company, they have unparalleled expertise in the fields of movement disorders, such a Parkinson’s disease and dyskinesia, and in the field of neuropsychology and cognition.
Our expertise and research capabilities are offered at a number of levels:
IN ADDITION, through our extensive network of clinical collaborators Motac offers ready access to clinical opinion-leaders and clinical trial specialists.
Mouse, rat and macaque models.
Models of cognitive disorders in NHP assessed through various testing procedures including computerized tests equivalent of their human counterpart (CANTAB battery).
Unique combination of motor and cognitive parkinsonian symptoms in the same individuals, facilitating the demonstration of positive effects affecting multiple domains.